165.55 3.51 (2.17%)

35.83% Fall from 52W High

2.7M NSE+BSE Volume

High vol. this week

NSE 06 Jun, 2025 3:31 PM (IST)

Trial Setback
SPARC ends Vibozilimod drug development after it fails to meet key goals in phase-2 trials See details